United Kingdom · Report · Written statement
UIN HLWS33
Favipiravir (FAVI) – Contingent Liability
Introduced
18 May 2026
Last action
18 May 2026 · Written statement
Status
Lords
Sponsors
—
Subjects
Discovery layer
Source updated
18 May 2026
Summary
My Honourable Friend the Parliamentary Under-Secretary of State for Public Health and Prevention (Sharon Hodgson MP) has made the following statement:The UK Health Security Agency (UKHSA) is receiving a supply of doses of the antiviral medicine favipiravi...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
18 May 2026
Written statement
My Honourable Friend the Parliamentary Under-Secretary of State for Public Health and Prevention (Sharon Hodgson MP) has made the following statement:The UK Health Security Agency (UKHSA) is receiving a supply of doses of the antiviral medicine favipiravi...
Source: Lords
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2026-05-18/HLWS33
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/1906271
- uk · ws-1906271 · source updated 18 May 2026